Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinomenine hydrochloride plus methotrexate versus leflunomide plus methotrexate for rheumatoid arthritis
ChiCTR-IPR-15007415Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Nov 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sinomenine in rheumatoid arthritis (RA) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: DAS28. Started Nov 2015; status: recruiting.
02
Drugs
sinomenine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-IPR-15007415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007415.